Conference Presentation, Fireside Chat
A Conversation with the 47th Vice President of the United States Joe Biden
- Focused ultrasound is projected to revolutionize therapy across 80+ indications in various development stages, potentially replacing surgery, radiation, or drugs for conditions including Alzheimer's, Parkinson's, epilepsy, tumors, and depression.
- The transition of focused ultrasound from concept to standard of care is expected to be a glacial process taking decades, though early patient data shows rapid relief from abdominal pain and renal failure within two weeks following one experimental session.
- The Department of Energy anticipates computing capabilities reaching a billion billion calculations per second within the next 2.5 years, enabling the aggregation of VA cancer data with supercomputers to identify treatment patterns.
- The National Cancer Institute formulary aims to reduce drug combination testing time from one to four years down to minutes, with participation expected to grow from three to nearly 15 companies.
- A projected global mobilization seeks to address an anticipated rise in cancer deaths from 14 million new cases and 8 million deaths in 2012 to 22 million cases and 13 million deaths, with goals to make most cancers chronic rather than terminal.
- The initiative plans to operationalize memorandums of understanding with 10 world leaders, including China, to pool resources, share data, and advance international collaboration on prevention, access, and affordability.
- Blood profiling technologies are expected to move cancer detection and prevention 1 to 25 years ahead of time, with a "Blood Profiling Atlas Pilot" launching to create an open database for liquid biopsies.
- Financial support is secured through the 21st Century Cures Act, allocating $6.8 billion for medical research and $1.8 billion for cancer, alongside a specific $476 million increase for the NCI.
- Partnerships include leveraging IBM's Watson supercomputer to sequence cancer genomes and provide treatment recommendations within minutes for military personnel, alongside an organization to restructure institutions for faster product development.
- The effort anticipates involving roughly 60 young entrepreneurs and nearly 80 private sector companies, while aiming to establish a consensus where the government significantly impacts health outcomes despite potential administrative changes.
- Public sentiment is expected to overwhelmingly support federal investment in research for cancer, opioid addiction, and Alzheimer's, driven by a cultural shift that breaks down silos and treats collaboration as the primary source of hope.
- Future goals include treating existing cancers as chronic diseases, administering vaccines for certain cancers similar to HPV, and ensuring patients receive the correct therapy on the first attempt.
- The breakdown of silos between immunotherapists, oncologists, and virologists is expected to continue, building on an inflection point reached five years prior to foster new approaches to data sharing, clinical trials, and prevention.
- The momentum of the Cancer Moonshot, which evolved into a movement involving nearly 300 summits, is expected to persist with 2016 actions from private sector entities to drive the "urgency of now."
- Prevention strategies will focus on identifying cancers before they develop using blood markers currently on the verge of realization, aiming to catch disease when it is most treatable.